7th Jul 2021 12:41
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | UDG HEALTHCARE PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 06 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
8,369,353 | 3.32% | 445,550 | 0.18% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
377,387 | 0.15% | 7,510,016 | 2.98% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
TOTAL: |
|
|
|
| |
8,746,740 | 3.47% | 7,955,566 | 3.16% | ||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 581 | 10.7049 GBP |
Purchase | 810 | 10.6900 GBP |
Purchase | 1,024 | 10.7014 GBP |
Purchase | 1,026 | 10.7100 GBP |
Purchase | 1,110 | 10.6950 GBP |
Purchase | 2,174 | 10.6985 GBP |
Purchase | 2,950 | 10.7015 GBP |
Purchase | 3,403 | 10.7000 GBP |
Purchase | 4,823 | 10.7045 GBP |
Purchase | 6,638 | 10.6988 GBP |
Purchase | 16,880 | 10.7094 GBP |
Purchase | 24,435 | 10.7053 GBP |
Purchase | 30,963 | 10.6994 GBP |
Purchase | 56,079 | 10.7110 GBP |
Sale | 1,982 | 10.6940 GBP |
Sale | 2,646 | 10.7000 GBP |
Sale | 2,921 | 10.6910 GBP |
Sale | 4,208 | 10.7012 GBP |
Sale | 4,904 | 10.6935 GBP |
Sale | 12,141 | 10.7001 GBP |
Sale | 17,026 | 10.7100 GBP |
Sale | 20,794 | 10.6975 GBP |
Sale | 61,527 | 10.7089 GBP |
(b) Derivatives transactions (other than options transactions)
Product Name | Nature of transaction | Number of relevant securities | Price per |
|
| unit | |
SWAP | Long | 3,719 | 10.6924 GBP |
CFD | Long | 4,208 | 10.7017 GBP |
SWAP | Long | 4,546 | 10.6903 GBP |
SWAP | Long | 9,636 | 10.6934 GBP |
SWAP | Short | 16 | 10.7100 GBP |
SWAP | Short | 584 | 10.7005 GBP |
SWAP | Short | 2,311 | 10.7035 GBP |
SWAP | Short | 3,665 | 10.7099 GBP |
CFD | Short | 3,703 | 10.7014 GBP |
SWAP | Short | 36,009 | 10.7040 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | NO |
Date of disclosure: | 7 Jul 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20210707005492/en/
Copyright Business Wire 2021
Related Shares:
BarclaysUDG.L